Pre-Market Earnings Report for January 30, 2026 : XOM, CVX, AXP, VZ, REGN, AON, CL, CNI, APD, IMO, SOFI, CHTR

Major U.S. and Canadian corporates are scheduled to report pre-market on 01/30/2026 with published consensus EPS forecasts: Exxon Mobil $1.68 (+0.60% YoY, 6 analysts; 2025 P/E 19.80 vs industry 24.20), Chevron $1.44 (-30.10% YoY, 7 analysts; 2025 P/E 23.54), American Express $3.55 (+16.78%, 11 analysts; 2025 P/E 23.18), Verizon $1.06 (-3.64%, 9 analysts), Regeneron $8.28 (-16.36%, 7 analysts), Aon $4.76 (+7.69%, 9 analysts), Colgate $0.91 (flat, 9 analysts), Canadian National $1.43 (+10.0%, 8 analysts), Air Products $3.04 (+6.29%, 8 analysts), Imperial Oil $1.36 (-19.53%, 2 analysts), SoFi $0.12 (+140.0%, 8 analysts), and Charter $10.40 (+2.97%, 7 analysts). The release catalog highlights mixed expected performance across sectors — notable YoY declines at Chevron, Regeneron and Imperial Oil and outsized growth expectations at SoFi — with several names showing P/E differentials versus industry peers that could inform positioning into the print.

Analysis

Market structure: The release set shows a bifurcation—integrated energy (XOM) is steady (+0.6% EPS) while Chevron (CVX) shows a -30% EPS step-down, signaling company-specific margin/asset items rather than a universal oil shock. Financials (AXP +16.8% EPS) and fintech (SOFI +140% EPS) are growth winners; defensive staples (CL flat) are stable. Expect short-term rotation into high-ROIC names (AXP, CNI, APD) and volatility in energy/biotech on idiosyncratic prints.

Risk assessment: Tail risks include an oil-price shock (±20% in 30 days) that would re-rate XOM/CVX and rail disruption that would hit CNI; biotech regulatory setbacks (Regeneron) or one-off charges could widen downside >15% for REGN. Time horizons: earnings shocks trade violently intraday–week, guidance rerates over 1–3 months, and structural share shifts play out over 6–12 months. Hidden dependencies: interplay of interest rates on AXP net interest income, and consumer credit losses for SOFI if unemployment rises >1ppt.

Trade implications: Favor tactical longs in XOM (lower beta, consistent beats) and AXP (consumer spending resiliency) while shorting CVX on squeezeable downside from quarter-specific issues; implement pair trades (long XOM, short CVX) size 1–2% NAV, 3-month horizon, target 8–12% relative return. Use option structures: buy REGN 3-month 10/20% put spread as asymmetric hedge and sell 30-day covered calls on CHTR to harvest premium; buy CNI outright for 12-month total return target +15%.

Contrarian angles: Consensus may over-penalize CVX and REGN for single-quarter misses—historically majors recover within 2–4 quarters if commodity backdrop stable. SOFI’s jump is priced for execution; downside risk is binary if credit costs reaccelerate—implied volation likely understates tail. Unintended consequence: crowding into XOM as a ‘safe energy’ trade could compress its forward yield advantage; watch flows for signs of mean reversion.

Key Decisions for Investors

• Establish a 2–3% NAV long position in XOM pre-earnings or immediately post-print if EPS >= $1.68 and guidance is stable; set stop-loss at -6% and target +8–12% over 3 months (reassess if oil > +15% moves).
• Open a 1.5–2% NAV pair trade: long XOM and short CVX (equal dollar), 3-month horizon; unwind if CVX trades back within 10% of its 90-day VWAP or CVX issues structural guidance improvements.
• Buy a 3-month REGN 10/20% put spread (buy 10% OTM put, sell 20% OTM put) sized to 0.5% NAV as downside insurance; if REGN prints > consensus and guidance improves, close at +40–60% of max gain.
• Initiate a 2% NAV long in CNI for 6–12 months targeting +15% total return; trim if rail volume growth lags consensus by >2ppt or union/strike risk materializes.
• Sell 30-day covered calls on CHTR representing 2–3% NAV exposure to collect premium; roll monthly and close if shares move >8% intramonth against position.